ALPHARADIN: 20 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
20
Total FAERS Reports
7 (35.0%)
Deaths Reported
16
Hospitalizations
20
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
First Report: 20130220 · Latest Report: 20140426
What Are the Most Common ALPHARADIN Side Effects?
#1 Most Reported
Thrombocytopenia
3 reports (15.0%)
#2 Most Reported
Pulmonary embolism
3 reports (15.0%)
#3 Most Reported
Hypotension
3 reports (15.0%)
All ALPHARADIN Side Effects by Frequency
No side effect data available.
Who Reports ALPHARADIN Side Effects? Age & Gender Data
Average age: 72.6 years. Most reports from: ES. View detailed demographics →
Is ALPHARADIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 13 | 3 | 12 |
| 2014 | 7 | 4 | 4 |
What Is ALPHARADIN Used For?
| Indication | Reports |
|---|---|
| Metastases to bone | 9 |
| Prostate cancer | 7 |
| Hormone-refractory prostate cancer | 6 |
| Prostate cancer metastatic | 5 |
Official FDA Label for ALPHARADIN
Official prescribing information from the FDA-approved drug label.